1. Home
  2. NEXA vs MPLT Comparison

NEXA vs MPLT Comparison

Compare NEXA & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$13.59

Market Cap

1.9B

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$12.57

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
MPLT
Founded
1956
2018
Country
Luxembourg
United States
Employees
N/A
133
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
NEXA
MPLT
Price
$13.59
$12.57
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$10.40
$32.67
AVG Volume (30 Days)
529.6K
1.3M
Earning Date
05-06-2026
05-28-2026
Dividend Yield
0.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.69
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.70
$9.10
52 Week High
$16.89
$40.43

Technical Indicators

Market Signals
Indicator
NEXA
MPLT
Relative Strength Index (RSI) N/A 27.87
Support Level N/A N/A
Resistance Level N/A $20.73
Average True Range (ATR) 0.00 2.54
MACD 0.00 -2.80
Stochastic Oscillator 0.00 11.57

Price Performance

Historical Comparison
NEXA
MPLT

About NEXA Nexa Resources S.A.

Nexa Resources SA operate large-scale, mechanized underground and open pit mines, as well as smelters. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: